IFNA7
interferon alpha 7, the group of Interferons
Basic information
Region (hg38): 9:21201468-21202205
Links
Phenotypes
GenCC
Source:
No genCC data.
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IFNA7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 13 | 16 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| inframe indel | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| splice region | 0 | |||||
| non coding | 0 | |||||
| Total | 0 | 0 | 13 | 3 | 0 |
Variants in IFNA7
This is a list of pathogenic ClinVar variants found in the IFNA7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
| Position | Type | Phenotype | Significance | ClinVar |
|---|---|---|---|---|
| 9-21201681-C-G | not specified | Uncertain significance (Apr 20, 2023) | ||
| 9-21201696-T-C | not specified | Uncertain significance (Jun 24, 2022) | ||
| 9-21201701-C-T | not specified | Uncertain significance (Jun 22, 2021) | ||
| 9-21201702-A-G | not specified | Likely benign (Jun 22, 2021) | ||
| 9-21201708-T-C | not specified | Uncertain significance (Aug 15, 2023) | ||
| 9-21201808-C-T | not specified | Uncertain significance (Feb 10, 2022) | ||
| 9-21201811-G-C | not specified | Uncertain significance (Sep 27, 2022) | ||
| 9-21201822-T-A | not specified | Uncertain significance (Sep 06, 2022) | ||
| 9-21201865-C-T | not specified | Uncertain significance (Jul 28, 2021) | ||
| 9-21201914-G-C | not specified | Uncertain significance (Feb 15, 2023) | ||
| 9-21201979-C-T | not specified | Uncertain significance (Dec 22, 2023) | ||
| 9-21202032-C-T | not specified | Uncertain significance (Jan 04, 2024) | ||
| 9-21202069-G-C | not specified | Likely benign (Sep 10, 2021) | ||
| 9-21202104-G-C | not specified | Uncertain significance (Jan 24, 2023) | ||
| 9-21202135-C-T | not specified | Uncertain significance (Jul 30, 2023) | ||
| 9-21202158-C-A | not specified | Likely benign (Jan 09, 2024) | ||
| 9-21202158-C-T | not specified | Uncertain significance (Mar 25, 2024) |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| IFNA7 | protein_coding | protein_coding | ENST00000239347 | 1 | 737 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -2.40 | 159 | 93.6 | 1.70 | 0.00000451 | 1242 |
| Missense in Polyphen | 29 | 18.626 | 1.557 | 258 | ||
| Synonymous | -3.86 | 66 | 36.4 | 1.81 | 0.00000166 | 360 |
| Loss of Function |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00 | 0.00 |
| Ashkenazi Jewish | ||
| East Asian | ||
| Finnish | ||
| European (Non-Finnish) | ||
| Middle Eastern | ||
| South Asian | ||
| Other |
dbNSFP
Source:
- Function
- FUNCTION: Produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);Kaposi,s sarcoma-associated herpesvirus infection - Homo sapiens (human);Jak-STAT signaling pathway - Homo sapiens (human);Influenza A - Homo sapiens (human);Autoimmune thyroid disease - Homo sapiens (human);Cytosolic DNA-sensing pathway - Homo sapiens (human);Necroptosis - Homo sapiens (human);Toll-like receptor signaling pathway - Homo sapiens (human);NOD-like receptor signaling pathway - Homo sapiens (human);Tuberculosis - Homo sapiens (human);Natural killer cell mediated cytotoxicity - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Hepatitis C - Homo sapiens (human);Hepatitis B - Homo sapiens (human);Measles - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);RIG-I-like receptor signaling pathway - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Herpes simplex infection - Homo sapiens (human);Regulation of toll-like receptor signaling pathway;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;PI3K-Akt Signaling Pathway;Toll-like Receptor Signaling Pathway;Cytokine Signaling in Immune system;JAK STAT MolecularVariation 1;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;Immune System;IFN alpha signaling;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;JAK STAT pathway and regulation;GPCR signaling-G alpha i;Regulation of IFNA signaling;Interferon alpha/beta signaling;Downstream signaling in naïve CD8+ T cells;Interferon Signaling
(Consensus)
Intolerance Scores
- loftool
- 0.662
- rvis_EVS
- 1.04
- rvis_percentile_EVS
- 91.21
Haploinsufficiency Scores
- pHI
- 0.0365
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0105
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- adaptive immune response;T cell activation involved in immune response;natural killer cell activation involved in immune response;humoral immune response;cell-cell signaling;blood coagulation;response to virus;regulation of signaling receptor activity;cytokine-mediated signaling pathway;B cell differentiation;positive regulation of peptidyl-serine phosphorylation of STAT protein;B cell proliferation;response to exogenous dsRNA;defense response to virus;type I interferon signaling pathway
- Cellular component
- extracellular region;extracellular space
- Molecular function
- cytokine activity;type I interferon receptor binding